Community
Our Promise, Our Part
Our vision is to discover, develop, and deliver transformational medicines for patients through internal innovation, collaborative partnerships, and strategic growth opportunities. We go beyond medicine by using our resources to strengthen health care in our communities and medical institutions.
Our Commitment to Patients
We go beyond treatment by leveraging our resources to help improve healthcare within our communities and across medical settings. Through partnerships with academic institutions, we also contribute to advancing knowledge and innovation in dermatology, in gastro-enterology and other therapeutic areas.
Understanding Patient Organizations
At Devonian, we value our partnerships with patient organizations as a key part of our commitment to maintaining a patient-centered approach to healthcare. We believe that healthcare should prioritize prevention, treatment, and disease management, while ensuring equitable access to high-quality medicines, services, and information.
We also recognize the importance of preserving the independence of patient organizations, so they can fully serve the needs of the patients and caregivers they represent.
Building Partnerships for Better Health
Collaborating with patient organizations and academic institutions creates meaningful opportunities to improve healthcare by addressing unmet needs and strengthening patient support—from research and diagnosis to treatment and beyond. These collaborations also help advance scientific knowledge in dermatology, in gastro-enterology and other therapeutic areas.
By sharing insights and lived experiences, patient organizations help deepen the understanding of patient realities. Together with academic partners, this collaboration fosters dialogue and innovation, helping to advance the healthcare landscape while building trust, mutual understanding, and shared goals for better health outcomes.
Our Commitment to Ethical Practices and Transparency
We adhere to the Innovative Medicines Canada (IMC) Code of Ethical Practices. To learn more, we encourage you to consult Section 3.3 — Guidelines for Transparency in Funding of Patient and Advocacy Groups (including Annex A) — the 2022 Code of Ethical Practices document listed on the Innovative Medicines Canada website.
Discover our 2026 partnerships.
At Devonian, we are proud to support Gutsy Walk for Crohn’s and Colitis Canada — the country’s largest community event dedicated to people living with Crohn’s disease and ulcerative colitis.
In Canada, more than 322,000 people live with these diseases, and every 48 minutes, someone is newly diagnosed. As a partner, we are helping advance research, improve treatments, and support essential programs for individuals and their loved ones.
This commitment reflects our dedication to community health, innovation, and improving quality of life.
Beyond our commitment to patient groups, we are equally dedicated to educating the next generation of healthcare professionals and strengthening a patient-centered approach in healthcare.
Devonian is proud to announce that, in 2026, we will support dermatology residents of the Faculty of medicine at the Université de Montréal (UdM) in their research and educational development. This academic funding is designed to advance both education and research in the field of dermatology, helping equip future specialists with the knowledge and tools needed to improve patient care.
This initiative reflects our broader commitment to innovation, education, and long-term impact in healthcare. Education is also an integral part of our strategy.
We wish the residents continued success as they progress in their educational journey.
